ASMB
Price:
$16.99
Market Cap:
$107.81M
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection...[Read more]
Industry
Biotechnology
IPO Date
2010-12-17
Stock Exchange
NASDAQ
Ticker
ASMB
According to Assembly Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -121.55%. This represents a change of 301.03% compared to the average of -30.31% of the last 4 quarters.
The mean historical ROE of Assembly Biosciences, Inc. over the last ten years is -59.86%. The current -121.55% ROE has changed 103.05% with respect to the historical average. Over the past ten years (40 quarters), ASMB's ROE was at its highest in in the June 2020 quarter at 2.72%. The ROE was at its lowest in in the December 2021 quarter at -35.67%.
Average
-59.86%
Median
-41.85%
Minimum
-148.98%
Maximum
-23.96%
Discovering the peaks and valleys of Assembly Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.66%
Maximum Annual ROE = -23.96%
Minimum Annual Increase = -48.73%
Minimum Annual ROE = -148.98%
Year | ROE | Change |
---|---|---|
2023 | -148.98% | 33.76% |
2022 | -111.38% | 44.89% |
2021 | -76.87% | 210.66% |
2020 | -24.74% | -30.76% |
2019 | -35.73% | -17.05% |
2018 | -43.08% | 13.84% |
2017 | -37.84% | -31.70% |
2016 | -55.41% | 131.24% |
2015 | -23.96% | -41.00% |
2014 | -40.62% | -48.73% |
The current ROE of Assembly Biosciences, Inc. (ASMB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-112.41%
5-year avg
-79.54%
10-year avg
-59.86%
Assembly Biosciences, Inc.’s ROE is less than Spero Therapeutics, Inc. (20.70%), greater than Achilles Therapeutics plc (-47.36%), greater than Instil Bio, Inc. (-55.57%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than CytomX Therapeutics, Inc. (-27.44%), greater than Nuvation Bio Inc. (-98.79%), greater than NextCure, Inc. (-57.63%),
Company | ROE | Market cap |
---|---|---|
20.70% | $71.07M | |
-47.36% | $29.58M | |
-55.57% | $92.68M | |
-47.64% | $8.20M | |
-27.44% | $93.74M | |
-98.79% | $692.60M | |
-57.63% | $39.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assembly Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assembly Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Assembly Biosciences, Inc.'s ROE?
How is the ROE calculated for Assembly Biosciences, Inc. (ASMB)?
What is the highest ROE for Assembly Biosciences, Inc. (ASMB)?
What is the 3-year average ROE for Assembly Biosciences, Inc. (ASMB)?
What is the 5-year average ROE for Assembly Biosciences, Inc. (ASMB)?
How does the current ROE for Assembly Biosciences, Inc. (ASMB) compare to its historical average?